These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8964919)

  • 1. A novel ganglioside, 9-O-acetyl GD1b, is recognized by serum antibodies in Guillain-Barré syndrome.
    Hitoshi S; Kusunoki S; Kon K; Chiba A; Waki H; Ando S; Kanazawa I
    J Neuroimmunol; 1996 May; 66(1-2):95-101. PubMed ID: 8964919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N; Yoshino H; Sato S; Ohno T; Miyatake T
    Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
    Ilyas AA; Cook SD; Mithen FA; Taki T; Kasama T; Handa S; Hamasaki H; Singhal BS; Li SC; Li YT
    J Neuroimmunol; 1998 Mar; 82(2):160-7. PubMed ID: 9585812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An acute axonal form of Guillain-Barré syndrome with autoantibody against ganglioside GD1b--a case report].
    Fujii H; Kondo T; Yasuda K; Hiraizumi Y; Yamazaki M; Yuki N
    No To Hattatsu; 1993 Jul; 25(4):379-84. PubMed ID: 8338702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.
    Kusunoki S; Chiba A; Kon K; Ando S; Arisawa K; Tate A; Kanazawa I
    Ann Neurol; 1994 May; 35(5):570-6. PubMed ID: 8179303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
    Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
    Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome.
    Walsh FS; Cronin M; Koblar S; Doherty P; Winer J; Leon A; Hughes RA
    J Neuroimmunol; 1991 Oct; 34(1):43-51. PubMed ID: 1894733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antibodies reacting with two neighboring gangliosides are induced in rabbits immunized with bovine brain gangliosides.
    Moyano AL; Comín R; Vilcaes AA; Funes SC; Roth GA; Irazoqui FJ; Nores GA
    Glycobiology; 2012 Dec; 22(12):1768-74. PubMed ID: 22843673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy.
    Baba H; Daune GC; Ilyas AA; Pestronk A; Cornblath DR; Chaudhry V; Griffin JW; Quarles RH
    J Neuroimmunol; 1989 Dec; 25(2-3):143-50. PubMed ID: 2584393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni.
    Vriesendorp FJ; Triggs WJ; Mayer RF; Koski CL
    J Neurol; 1995 Jul; 242(7):460-5. PubMed ID: 7595678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome.
    von Wulffen H; Hartard C; Scharein E
    J Infect Dis; 1994 Oct; 170(4):828-33. PubMed ID: 7930724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.